TASCOM Co.,Ltd. (XKON:336040)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,200.00
+5.00 (0.12%)
At close: Mar 5, 2026
0.00%
Market Cap 23.97B
Revenue (ttm) 5.53B
Net Income (ttm) -1.74B
Shares Out 5.71M
EPS (ttm) -824.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46
Average Volume 69
Open 4,195.00
Previous Close 4,195.00
Day's Range 3,900.00 - 4,200.00
52-Week Range 2,400.00 - 5,280.00
Beta 0.40
RSI 61.18
Earnings Date n/a

About TASCOM

TASCOM Co.,Ltd. engages in the research and development, manufacturing, and sales of in vitro diagnostic medical devices. The company offers SimplexTAS, an in vitro diagnostic medical device for point-of-care diagnosis that can diagnose and monitor various diseases, such as diabetes, hyperlipidemia, liver disease, kidney disease, and infections. It also provides pen needles and syringes. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquarte... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 336040
Full Company Profile

Financial Performance

In 2018, TASCOM's revenue was 5.53 billion, an increase of 84.97% compared to the previous year's 2.99 billion. Losses were -1.74 billion, 35.2% more than in 2017.

Financial Statements

News

There is no news available yet.